These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22644707)

  • 1. Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.
    Yang JJ; Liu CY; Quan LH; Liao YH
    AAPS PharmSciTech; 2012 Sep; 13(3):816-25. PubMed ID: 22644707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
    Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.
    Pinto JT; Zellnitz S; Guidi T; Schiaretti F; Schroettner H; Paudel A
    Pharm Res; 2021 Jun; 38(6):1107-1123. PubMed ID: 34114162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
    Gong QQ; Tay JYS; Veronica N; Xu J; Heng PWS; Zhang YP; Liew CV
    Pharm Dev Technol; 2023 Feb; 28(2):164-175. PubMed ID: 36683577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ; Chan LW; Heng PWS
    Mol Pharm; 2018 Apr; 15(4):1635-1642. PubMed ID: 29490144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
    Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.
    Tan BM; Chan LW; Heng PW
    Pharm Res; 2016 Aug; 33(8):1923-35. PubMed ID: 27091033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM; Wood O; Ooi J; Traini D
    Int J Pharm; 2011 Sep; 416(1):129-35. PubMed ID: 21708238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T; Tong S; Liao Q; Pan L; Cheng M; Rantanen J; Cun D; Yang M
    Int J Pharm; 2023 Mar; 635():122702. PubMed ID: 36773729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
    Khanal D; Kim J; Zhang J; Ke WR; Holl MMB; Chan HK
    Int J Pharm; 2023 Feb; 632():122563. PubMed ID: 36586629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM; Mescher A; Schroettner H; Achelis L; Walzel P; Urbanetz NA
    Eur J Pharm Biopharm; 2012 Sep; 82(1):194-204. PubMed ID: 22595133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
    Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
    Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W; Nokhodchi A
    Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ; Lee HG; Kwon YB; Kim JY; Rhee YS; Chon J; Park ES; Kim DW; Park CW
    Eur J Pharm Sci; 2018 May; 117():279-289. PubMed ID: 29510172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K; Srichana T
    Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.